TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 4 | -3 | 1 | 3 | -3 | -16 | -40 | -9 |
| P | %wins | 25 | 50 | 75 | 25 | 25 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/24/09 17:35 | 11/24/09 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mueller Hans | PA | D | P | 20 | 5.10 | 0 | 4 | 67 | 10 | D | -56 | -23 | -6 | -34 | -38 | -15 | 1 | 0 | -2 | -1 | 5 | -3 | -24 | -46 | |
11/12/09 17:58 | 11/12/09 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mueller Hans | PA | D | P | 10 | 5.17 | 0 | 2 | 50 | 6 | D | -59 | -40 | -19 | -38 | -32 | -28 | -12 | -6 | -5 | 1 | -2 | -4 | 7 | -44 | |
8/6/09 16:48 | 8/4/09 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mueller Hans | PA | D | P | 10 | 6.82 | 0 | 2 | 60 | 4 | D | 3 | -53 | -1 | 15 | 13 | 17 | 7 | 8 | 1 | 10 | 10 | -15 | -31 | -49 | |
5/11/09 11:17 | 5/8/09 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mueller Hans | PA | D | P | 15 | 6.09 | 0 | 3 | New | 3 | D | -28 | -57 | -26 | -17 | -3 | 10 | 4 | 5 | -4 | -5 | 0 | 12 | -15 | -20 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |